1,2,3,4-Tetrahydroisoquinolin-6-ol hydrobromide, 95.0%, 10g

[1-[(3,5-Dimethyl-1H-pyrrol-2-yl)(3,5-dimethyl-2H-pyrrol-2-ylidene)methyl]-4-iodobenzene](difluoroborane)>98.0%(HPLC)200mg

(R)-Methyl 2-(pyrrolidin-3-yloxy)acetate 4-methylbenzenesulfonate, 97.0%, 100mg

p-Toluic acid, 98%, for synthesis, 250 g, plastic packaging.

1-(4-Bromobenzyl)imidazole, 95.0%, 1g

4-Chloropyridine-3-sulfonamide, 95.0%, 10g

1-Hexyl-2,3-dimethyl-1H-imidazol-3-ium chloride, 98%, 5g

Volumetric pipettes 1 marking, class AS, 100 ml, 6 pieces

Methyl 2-amino-5-iodothiazole-4-carboxylate, 97%, 100mg

4-Ethyl-1,2-dimethylbenzene, 95.0%, 1g

2-(3-Thiocarbamoylphenyl)benzimidazole, 5g

2,2-Dimethyl-6-nitro-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one, 95.0%, 5g

1-[5-(Methylamino)-1,2,4-thiadiazol-3-yl]-2-propanone, 98%, 100mg